Aranorosin circumvents arbekacin-resistance in MRSA by inhibiting the bifunctional enzyme AAC(6′)/APH(2″)

This publication has 12 references indexed in Scilit:

• Biverlactones A–D, new circumventors of arbekacin resistance in MRSA, produced by Penicillium sp. FKI-4429
  Tetrahedron, 2011
• Trends of Arbekacin-resistant MRSA Strains in Japanese Hospitals (1979 to 2000)
  The Journal of Antibiotics, 2006
• Functional Characterization of a Multiple-Antibiotic Resistant Plasmid from Clinical Isolates of Methicillin-Resistant Staphylococcus aureus
  Kansenshogaku Zasshi, 2001
• Semisynthetic aminoglycoside antibiotics: Development and enzymatic modifications
  Journal of Infection and Chemotherapy, 1999
• Multiple-Antibiotic-Resistant Pathogenic Bacteria -- A Report on the Rockefeller University Workshop
  New England Journal of Medicine, 1994
• Eurystatins A and B, new prolyl endopeptidase inhibitors. III. Fermentation and controlled biosynthesis of eurystatin analogs by Streptomyces eurythermus.
  The Journal of Antibiotics, 1994
• Structures of enzymatically modified products of arbekacin by methicillin-resistant Staphylococcus aureus.
  The Journal of Antibiotics, 1993
• Aranorosin, a novel antibiotic from Pseudoarachiniotus roseus. I. Taxonomy, fermentation, isolation, chemical and biological properties.
  The Journal of Antibiotics, 1988
• SYNTHESES OF 1-N-{(S)-4-AMINO-2-HYDROXYBUTYRYL}-KANAMYCIN B AND -3'', 4''-DIDEOXYKANAMYCIN B ACTIVE AGAINST KANAMYCIN-RESISTANT BACTERIA
  The Journal of Antibiotics, 1973
• SYNTHESES OF (S)-4-AMINO-2-HYDROXYBUTYRYL DERIVATIVES OF 3'', 4''-DIDEOXYKANAMYCIN B AND THEIR ANTIBACTERIAL ACTIVITIES
  The Journal of Antibiotics, 1973